Citations (122)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (20)
Tarun Garg, Saurav Bhandari, Goutam Rath & Amit K. Goyal. (2015) Current strategies for targeted delivery of bio-active drug molecules in the treatment of brain tumor. Journal of Drug Targeting 23:10, pages 865-887.
Read now
Read now
Jennifer H Kang & Cory Adamson. (2015) Novel chemotherapeutics and other therapies for treating high-grade glioma. Expert Opinion on Investigational Drugs 24:10, pages 1361-1379.
Read now
Read now
Nikhil G Thaker & Ian F Pollack. (2009) Molecularly targeted therapies for malignant glioma: rationale for combinatorial strategies. Expert Review of Neurotherapeutics 9:12, pages 1815-1836.
Read now
Read now
Valentino Laquintana, Adriana Trapani, Nunzio Denora, Fan Wang, James M Gallo & Giuseppe Trapani. (2009) New strategies to deliver anticancer drugs to brain tumors. Expert Opinion on Drug Delivery 6:10, pages 1017-1032.
Read now
Read now
Javier Gonzalez & John de Groot. (2008) Combination therapy for malignant glioma based on PTEN status. Expert Review of Anticancer Therapy 8:11, pages 1767-1779.
Read now
Read now
Warren P Mason. (2008) Emerging drugs for malignant glioma. Expert Opinion on Emerging Drugs 13:1, pages 81-94.
Read now
Read now
Andrew Chi, Andrew D Norden & Patrick Y Wen. (2007) Inhibition of angiogenesis and invasion in malignant gliomas. Expert Review of Anticancer Therapy 7:11, pages 1537-1560.
Read now
Read now
Marta Penas-Prado & Mark R Gilbert. (2007) Molecularly targeted therapies for malignant gliomas: advances and challenges. Expert Review of Anticancer Therapy 7:5, pages 641-661.
Read now
Read now
Andrew S Chi & Patrick Y Wen. (2007) Inhibiting kinases in malignant gliomas. Expert Opinion on Therapeutic Targets 11:4, pages 473-496.
Read now
Read now
David E Gerber & John Laterra. (2007) Emerging monoclonal antibody therapies for malignant gliomas. Expert Opinion on Investigational Drugs 16:4, pages 477-494.
Read now
Read now
Sith Sathornsumetee, Kaitlyn A Vredenburgh, Kathryn P Lattimore & Jeremy N Rich. (2007) Malignant glioma drug discovery – targeting protein kinases. Expert Opinion on Drug Discovery 2:1, pages 1-17.
Read now
Read now
Herbert B Newton. (2006) Advances in strategies to improve drug delivery to brain tumors. Expert Review of Neurotherapeutics 6:10, pages 1495-1509.
Read now
Read now
Sith Sathornsumetee & Jeremy N Rich. (2006) New treatment strategies for malignant gliomas. Expert Review of Anticancer Therapy 6:7, pages 1087-1104.
Read now
Read now
Patrick Y Wen, Santosh Kesari & Jan Drappatz. (2006) Malignant gliomas: strategies to increase the effectiveness of targeted molecular treatment. Expert Review of Anticancer Therapy 6:5, pages 733-754.
Read now
Read now
Maciej S Lesniak. (2006) Gene therapy for malignant glioma. Expert Review of Neurotherapeutics 6:4, pages 479-488.
Read now
Read now
Robert Cavaliere & Herbert Newton. (2006) Cytotoxic and molecular chemotherapy for high-grade glioma: an emerging strategy for the future. Expert Opinion on Pharmacotherapy 7:6, pages 749-765.
Read now
Read now
Y. Yang, N. Shao, G. Luo, L. Li, P. Nilsson‐Ehle & N. Xu$suffix/text()$suffix/text(). (2006) Relationship between PTEN gene expression and differentiation of human glioma. Scandinavian Journal of Clinical and Laboratory Investigation 66:6, pages 469-475.
Read now
Read now
M Kelly Nicholas, Rimas Lukas & Samir Bangalore. (2005) Chemotherapy for malignant glioma. Expert Review of Neurotherapeutics 5:sup1, pages 41-49.
Read now
Read now
Herbert B Newton. (2005) Molecular neuro-oncology and the development of targeted therapeutic strategies for brain tumors Part 5: apoptosis and cell cycle. Expert Review of Anticancer Therapy 5:2, pages 355-378.
Read now
Read now
Herbert B Newton. (2005) Molecular neuro-oncology and the development of targeted therapeutic strategies for brain tumors Part 4: p53 signaling pathway. Expert Review of Anticancer Therapy 5:1, pages 177-191.
Read now
Read now
Articles from other publishers (102)
Ashif Ahamed, Mahmadul Hasan, Arijit Samanta, Syed Sahajada Mahafujul Alam, Zarnain Jamil, Safdar Ali & Mehboob Hoque. (2023) Prospective pharmacological potential of cryptotanshinone in cancer therapy. Pharmacological Research - Modern Chinese Medicine 9, pages 100308.
Crossref
Crossref
Shuyan Han, Hongmei Hou, Yiren Zhang, Zhongxiang Fang, Yun Li, Le Zhang, Yandan Wang, Shijia Zhang, Hui Zhang, Qingzhe Jin, Gangcheng Wu & Xingguo Wang. (2023) Oleuropein and its hydrolysate from extra virgin olive oil inhibit breast cancer cells proliferation interfering with the PI3K-AKT signal pathway. Journal of Functional Foods 110, pages 105880.
Crossref
Crossref
Jizhong Han, Huajiang Deng, Yu Xiong, Xiangguo Xia, Changshun Bao, Ligang Chen, Qin Zhao, Shunjie Zhong, Lilei Peng & Chuanhong Zhong. (2022) Reduced PTCH2 expression is associated with glioma development through its regulation of the PTEN/AKT signaling pathway. Biochemical and Biophysical Research Communications 627, pages 76-83.
Crossref
Crossref
Tingfeng Wu, Yongxiu Chen, Liying Yang, Xiangyu Wang, Ke'en Chen & Dianshuang Xu. (2022) Ribonuclease A Family Member 2 Promotes the Malignant Progression of Glioma Through the PI3K/Akt Signaling Pathway. Frontiers in Oncology 12.
Crossref
Crossref
Herbert B. Newton & Ekokobe Fonkem. 2022. Handbook of Neuro-Oncology Neuroimaging. Handbook of Neuro-Oncology Neuroimaging
9
24
.
Herbert B. Newton & Ekokobe Fonkem. 2022. Handbook of Neuro-Oncology Neuroimaging. Handbook of Neuro-Oncology Neuroimaging
45
58
.
Srishti Agarwal, Priyadharshni Muniyandi, Toru Maekawa & D. Sakthi Kumar. (2018) Vesicular systems employing natural substances as promising drug candidates for MMP inhibition in glioblastoma: A nanotechnological approach. International Journal of Pharmaceutics 551:1-2, pages 339-361.
Crossref
Crossref
Yan Wang, Xiaohui Sun, Kaihua Ji, Liqing Du, Chang Xu, Ningning He, Jinhan Wang, Yang Liu & Qiang Liu. (2018) Sirt3-mediated mitochondrial fission regulates the colorectal cancer stress response by modulating the Akt/PTEN signalling pathway. Biomedicine & Pharmacotherapy 105, pages 1172-1182.
Crossref
Crossref
Valéria Pereira Ferrer, Vivaldo Moura Neto & Rolf Mentlein. (2018) Glioma infiltration and extracellular matrix: key players and modulators. Glia 66:8, pages 1542-1565.
Crossref
Crossref
Herbert B. Newton. 2018. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy
513
525
.
Herbert B. Newton. 2018. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy
503
511
.
Katsunori Nochioka, Hiroaki Okuda, Kouko Tatsumi, Shoko Morita, Nahoko Ogata & Akio Wanaka. (2016) Hedgehog Signaling Components Are Expressed in Choroidal Neovascularization in Laser-induced Retinal Lesion. Acta Histochemica et Cytochemica ACTA HISTOCHEMICA ET CYTOCHEMICA 49:2, pages 67-74.
Crossref
Crossref
Herbert B. Newton. 2016. Handbook of Neuro-Oncology Neuroimaging. Handbook of Neuro-Oncology Neuroimaging
41
53
.
Herbert B. Newton. 2016. Handbook of Neuro-Oncology Neuroimaging. Handbook of Neuro-Oncology Neuroimaging
9
22
.
Marzia Toscano, Silvia Palumbo, Paolo Tini, Clelia Miracco, Giovanni Luca Gravina & Sergio Comincini. 2016. Radiobiology of Glioblastoma. Radiobiology of Glioblastoma
209
224
.
Travis J. Jerde. (2015) Phosphatase and Tensin Homologue: Novel Regulation by Developmental Signaling. Journal of Signal Transduction 2015, pages 1-13.
Crossref
Crossref
Susann Herzog, Matthias Alexander Fink, Kerstin Weitmann, Claudius Friedel, Stefan Hadlich, Sönke Langner, Katharina Kindermann, Tobias Holm, Andreas Böhm, Eskil Eskilsson, Hrvoje Miletic, Markus Hildner, Michael Fritsch, Silke Vogelgesang, Christoph Havemann, Christoph Alexander Ritter, Henriette Elisabeth Meyer zu Schwabedissen, Bernhard Rauch, Wolfgang Hoffmann, Heyo Klaus Kroemer, Henry Schroeder & Sandra Bien-Möller. (2015) Pim1 kinase is upregulated in glioblastoma multiforme and mediates tumor cell survival. Neuro-Oncology 17:2, pages 223-242.
Crossref
Crossref
Herbert B. Newton & Jose J. Otero. 2015. Epilepsy and Brain Tumors. Epilepsy and Brain Tumors
11
28
.
Alok R Singh, Shweta Joshi, Elizabeth George & Donald L Durden. (2014) Anti-tumor effect of a novel PI3-kinase inhibitor, SF1126, in 12 V-Ha-Ras transgenic mouse glioma model. Cancer Cell International 14:1.
Crossref
Crossref
Khushboo Sharma, Ngoc Le, Moureq Alotaibi & David Gewirtz. (2014) Cytotoxic Autophagy in Cancer Therapy. International Journal of Molecular Sciences 15:6, pages 10034-10051.
Crossref
Crossref
Stanislaw R. Burzynski & Sonali S. Patil. (2014) The Effect of Antineoplastons A10 and AS2-1 and Metabolites of Sodium Phenylbutyrate on Gene Expression in Glioblastoma Multiforme. Journal of Cancer Therapy 05:10, pages 929-945.
Crossref
Crossref
Herbert B. Newton. 2012. Textbook of Uncommon Cancer. Textbook of Uncommon Cancer
721
732
.
Corrado Romano & Carmelo Schepis. (2012) PTEN Gene: A Model for Genetic Diseases in Dermatology. The Scientific World Journal 2012, pages 1-8.
Crossref
Crossref
Nicholas A. Butowski & Susan M. Chang. 2012. Neuro-Oncology Part II. Neuro-Oncology Part II
937
945
.
Serdar Korur, Maria Maddalena Lino & Adrian Merlo. 2012. Advances in Cancer Stem Cell Biology. Advances in Cancer Stem Cell Biology
105
121
.
Hiroyuki Uchida, Kazunori Arita, Shunji Yunoue, Hajime Yonezawa, Yoshinari Shinsato, Hiroto Kawano, Hirofumi Hirano, Ryosuke Hanaya & Hiroshi Tokimura. (2011) Role of sonic hedgehog signaling in migration of cell lines established from CD133-positive malignant glioma cells. Journal of Neuro-Oncology 104:3, pages 697-704.
Crossref
Crossref
M. M. Lino & A. Merlo. (2010) PI3Kinase signaling in glioblastoma. Journal of Neuro-Oncology 103:3, pages 417-427.
Crossref
Crossref
Manuel Nieto-SampedroBeatriz Valle-ArgosDiego Gómez-NicolaAlfonso Fernández-MayoralasManuel Nieto-Díaz. (2011) Inhibitors of Glioma Growth that Reveal the Tumour to the Immune System. Clinical Medicine Insights: Oncology 5, pages CMO.S7685.
Crossref
Crossref
Giovanni Giurdanella, Carla Motta, Stefano Muriana, Valeria Arena, Carmelina Daniela Anfuso, Gabriella Lupo & Mario Alberghina. (2011) Cytosolic and calcium-independent phospholipase A2 mediate glioma-enhanced proangiogenic activity of brain endothelial cells. Microvascular Research 81:1, pages 1-17.
Crossref
Crossref
Abhijit Guha & David Omahen. 2011. Youmans Neurological Surgery. Youmans Neurological Surgery
1124
1132
.
Maria Maddalena Lino, Adrian Merlo & Jean-Louis Boulay. (2010) Notch signaling in glioblastoma: a developmental drug target?. BMC Medicine 8:1.
Crossref
Crossref
Donald J. AbrahamRobertson Graeme. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
223
294
.
Fan Yang, Christine Brown, Ralf Buettner, Michael Hedvat, Renate Starr, Anna Scuto, Anne Schroeder, Michael Jensen & Richard Jove. (2010) Sorafenib Induces Growth Arrest and Apoptosis of Human Glioblastoma Cells through the Dephosphorylation of Signal Transducers and Activators of Transcription 3. Molecular Cancer Therapeutics 9:4, pages 953-962.
Crossref
Crossref
P. C. De Witt Hamer. (2010) Small molecule kinase inhibitors in glioblastoma: a systematic review of clinical studies. Neuro-Oncology 12:3, pages 304-316.
Crossref
Crossref
H. Mure, K. Matsuzaki, K. T. Kitazato, Y. Mizobuchi, K. Kuwayama, T. Kageji & S. Nagahiro. (2009) Akt2 and Akt3 play a pivotal role in malignant gliomas. Neuro-Oncology 12:3, pages 221-232.
Crossref
Crossref
Herbert B. Newton. 2010. Glioblastoma. Glioblastoma
1
42
.
Carmelina Daniela Anfuso, Giovanni Giurdanella, Carla Motta, Stefano Muriana, Gabriella Lupo, Nicola Ragusa & Mario Alberghina. (2009) PKCα-MAPK/ERK-phospholipase A2 signaling is required for human melanoma-enhanced brain endothelial cell proliferation and motility. Microvascular Research 78:3, pages 338-357.
Crossref
Crossref
Woo‐Young Kim & Ho‐Young Lee. (2009) Brain angiogenesis in developmental and pathological processes: mechanism and therapeutic intervention in brain tumors. The FEBS Journal 276:17, pages 4653-4664.
Crossref
Crossref
Martin R. Graf, Wentao Jia, Ross S. Johnson, Paul Dent, Clint Mitchell & Roger M. Loria. (2009) Autophagy and the functional roles of Atg5 and beclin-1 in the anti-tumor effects of 3β androstene 17α diol neuro-steroid on malignant glioma cells. The Journal of Steroid Biochemistry and Molecular Biology 115:3-5, pages 137-145.
Crossref
Crossref
Ryad Djedid, Robert Kiss & Florence Lefranc. (2009) Targeted therapy of glioblastomas: a 5-year view. Therapy 6:3, pages 351-370.
Crossref
Crossref
Maddalena Lino & Adrian Merlo. (2009) Translating biology into clinic: the case of glioblastoma. Current Opinion in Cell Biology 21:2, pages 311-316.
Crossref
Crossref
Herbert B. Newton. (2009) Bevacizumab: Review of Development, Pharmacology, and Application to Brain Tumors. Clinical Medicine. Therapeutics 1, pages CMT.S2042.
Crossref
Crossref
F. Lefranc, M. Rynkowski, O. DeWitte & R. Kiss. 2009. Advances and Technical Standards in Neurosurgery. Advances and Technical Standards in Neurosurgery
3
35
.
Pauline Chugh, Birgit Bradel-Tretheway, Carlos MR Monteiro-Filho, Vicente Planelles, Sanjay B Maggirwar, Stephen Dewhurst & Baek Kim. (2008) Akt inhibitors as an HIV-1 infected macrophage-specific anti-viral therapy. Retrovirology 5:1.
Crossref
Crossref
Jeremy Marsh, Purna Mukherjee & Thomas N. Seyfried. (2008) Akt-Dependent Proapoptotic Effects of Dietary Restriction on Late-Stage Management of a Phosphatase and Tensin Homologue/Tuberous Sclerosis Complex 2–Deficient Mouse Astrocytoma. Clinical Cancer Research 14:23, pages 7751-7762.
Crossref
Crossref
Junya Fukai, Hideyuki Yokote, Ryuya Yamanaka, Tokuzo Arao, Kazuto Nishio & Toru Itakura. (2008) EphA4 promotes cell proliferation and migration through a novel EphA4-FGFR1 signaling pathway in the human glioma U251 cell line. Molecular Cancer Therapeutics 7:9, pages 2768-2778.
Crossref
Crossref
Mehmet Yasar Kaynar, Galip Zihni Sanus, Hakan Hnimoglu, Tibet Kacira, Rahsan Kemerdere, Pinar Atukeren, Koray Gumustas, Bulent Canbaz & Taner Tanriverdi. (2008) Expression of hypoxia inducible factor-1α in tumors of patients with glioblastoma multiforme and transitional meningioma. Journal of Clinical Neuroscience 15:9, pages 1036-1042.
Crossref
Crossref
Herbert B. Newton. (2008) Glioblastoma multiforme. Current Treatment Options in Neurology 10:4, pages 285-294.
Crossref
Crossref
Halldora K. Thorarinsdottir, Mariarita Santi, Robert McCarter, Elisabeth J. Rushing, Robert Cornelison, Alessandra Jales & Tobey J. MacDonald. (2008) Protein Expression of Platelet-Derived Growth Factor Receptor Correlates with Malignant Histology and PTEN with Survival in Childhood Gliomas. Clinical Cancer Research 14:11, pages 3386-3394.
Crossref
Crossref
Ren LiuBo TianMarla Gearing, Stephen Hunter, Keqiang Ye & Zixu Mao. (2008) Cdk5-mediated regulation of the PIKE-A-Akt pathway and glioblastoma cell invasion. Proceedings of the National Academy of Sciences 105:21, pages 7570-7575.
Crossref
Crossref
Florence Lefranc & Robert Kiss. (2008) The Sodium Pump α1 Subunit as a Potential Target to Combat Apoptosis-Resistant Glioblastomas. Neoplasia 10:3, pages 198-206.
Crossref
Crossref
Herbert B. Newton, Abhik Ray-Chaudhury & Mark G. Malkin. 2008. Handbook of Neuro-Oncology NeuroImaging. Handbook of Neuro-Oncology NeuroImaging
36
49
.
Herbert B. Newton, Abhik Ray-Chaudhury & Mark G. Malkin. 2008. Handbook of Neuro-Oncology NeuroImaging. Handbook of Neuro-Oncology NeuroImaging
9
19
.
Corrado Romano. 2008. Neurocutaneous Disorders Phakomatoses and Hamartoneoplastic Syndromes. Neurocutaneous Disorders Phakomatoses and Hamartoneoplastic Syndromes
483
489
.
Avery A. Sandberg & John F. Stone. 2008. The Genetics and Molecular Biology of Neural Tumors. The Genetics and Molecular Biology of Neural Tumors
343
430
.
Ichiro Nakano, Michael Masterman-Smith, Kuniyasu Saigusa, Andres A. Paucar, Steve Horvath, Lorelei Shoemaker, Momoko Watanabe, Alejandra Negro, Ruchi Bajpai, Amy Howes, Vincent Lelievre, James A. Waschek, Jorge A. Lazareff, William A. Freije, Linda M. Liau, Richard J. Gilbertson, Timothy F. Cloughesy, Daniel H. Geschwind, Stanley F. Nelson, Paul S. Mischel, Alexey V. Terskikh & Harley I. Kornblum. (2008) Maternal embryonic leucine zipper kinase is a key regulator of the proliferation of malignant brain tumors, including brain tumor stem cells. Journal of Neuroscience Research 86:1, pages 48-60.
Crossref
Crossref
Robert C Castellino & Donald L Durden. (2007) Mechanisms of Disease: the PI3K–Akt–PTEN signaling node—an intercept point for the control of angiogenesis in brain tumors. Nature Clinical Practice Neurology 3:12, pages 682-693.
Crossref
Crossref
Dieta Brandsma & Martin J van den Bent. (2007) Molecular targeted therapies and chemotherapy in malignant gliomas. Current Opinion in Oncology 19:6, pages 598-605.
Crossref
Crossref
Xue Qing Lun, Hongyuan Zhou, Tommy Alain, Beichen Sun, Limei Wang, John W. Barrett, Marianne M. Stanford, Grant McFadden, John Bell, Donna L. Senger & Peter A. Forsyth. (2007) Targeting Human Medulloblastoma: Oncolytic Virotherapy with Myxoma Virus Is Enhanced by Rapamycin. Cancer Research 67:18, pages 8818-8827.
Crossref
Crossref
Antonio M.P. Omuro, Sandrine Faivre & Eric Raymond. (2007) Lessons learned in the development of targeted therapy for malignant gliomas. Molecular Cancer Therapeutics 6:7, pages 1909-1919.
Crossref
Crossref
Huda H. Al-Khalaf, Boleslaw Lach, Ayman Allam, Ahmed AlKhani, Salman A. Alrokayan & Abdelilah Aboussekhra. (2007) The p53/p21 DNA damage-signaling pathway is defective in most meningioma cells. Journal of Neuro-Oncology 83:1, pages 9-15.
Crossref
Crossref
P M Martin, S E Aeder, C A Chrestensen, T W Sturgill & I M Hussaini. (2006) Phorbol 12-myristate 13-acetate and serum synergize to promote rapamycin-insensitive cell proliferation via protein kinase C-eta. Oncogene 26:3, pages 407-414.
Crossref
Crossref
Iacopo Sardi, Duccio Cavalieri & Maura Massimino. (2007) Emerging Treatments and Gene Expression Profiling in High-Risk Medulloblastoma. Pediatric Drugs 9:2, pages 81-96.
Crossref
Crossref
Anders I. Persson, QiWen Fan, Joanna J. Phillips & William A. Weiss. 2007. Neurobiology of Disease. Neurobiology of Disease
433
444
.
Agnieszka Korfel & Eckhard Thiel. 2007. Targeted Therapies in Cancer. Targeted Therapies in Cancer
123
133
.
Debra L. Smith, Laura K. Nolden, Gordon B. Mills & Yiling Lu. 2007. Apoptosis, Senescence, and Cancer. Apoptosis, Senescence, and Cancer
313
334
.
Maciej S. Lesniak & Alessandro Olivi. 2007. High-Grade Gliomas. High-Grade Gliomas
419
430
.
Warren P MasonRoger Stupp. (2006) Recent advances in the medical therapy of high-grade gliomas. Future Neurology 1:6, pages 831-842.
Crossref
Crossref
T. YAGYU, Y. TSUJI, S. HARUTA, T. KITANAKA, Y. YAMADA, R. KAWAGUCHI, S. KANAYAMA, Y. TANASE, N. KURITA & H. KOBAYASHI. (2006) Activation of mammalian target of rapamycin in postmenopausal ovarian endometriosis. International Journal of Gynecological Cancer 16:4, pages 1545-1551.
Crossref
Crossref
Krishan Bansal, Muh Lii Liang & James T. Rutka. (2016) Molecular Biology of Human Gliomas. Technology in Cancer Research & Treatment 5:3, pages 185-194.
Crossref
Crossref
Angiolo Gadducci, Stefania Cosio & Andrea Riccardo Genazzani. (2006) Old and new perspectives in the pharmacological treatment of advanced or recurrent endometrial cancer: Hormonal therapy, chemotherapy and molecularly targeted therapies. Critical Reviews in Oncology/Hematology 58:3, pages 242-256.
Crossref
Crossref
Markus Hutterer, Eberhard Gunsilius & Guenther Stockhammer. (2006) Molecular therapies for malignant gliomaMolekulare Therapien bei malignen Gliomen. Wiener Medizinische Wochenschrift 156:11-12, pages 351-363.
Crossref
Crossref
C-S Kang, Z-Y Zhang, Z-F Jia, G-X Wang, M-Z Qiu, H-X Zhou, S-Z Yu, J Chang, H Jiang & P-Y Pu. (2006) Suppression of EGFR expression by antisense or small interference RNA inhibits U251 glioma cell growth in vitro and in vivo. Cancer Gene Therapy 13:5, pages 530-538.
Crossref
Crossref
William A. Vandergrift & Sunil J. Patel. (2006) Convection-enhanced delivery of immunotoxins and radioisotopes for treatment of malignant gliomas. Neurosurgical Focus 20:4, pages E13.
Crossref
Crossref
Florence Lefranc & Robert Kiss. (2006) Autophagy, the Trojan horse to combat glioblastomas. Neurosurgical Focus 20:4, pages E7.
Crossref
Crossref
Herbert B. Newton, Abhik Ray-Chaudhury & Robert Cavaliere. (2006) Brain Tumor Imaging and Cancer Management. Topics in Magnetic Resonance Imaging 17:2, pages 127-136.
Crossref
Crossref
Nicholas A. Butowski, Patricia K. Sneed & Susan M. Chang. (2006) Diagnosis and Treatment of Recurrent High-Grade Astrocytoma. Journal of Clinical Oncology 24:8, pages 1273-1280.
Crossref
Crossref
Heidi S. Phillips, Samir Kharbanda, Ruihuan Chen, William F. Forrest, Robert H. Soriano, Thomas D. Wu, Anjan Misra, Janice M. Nigro, Howard Colman, Liliana Soroceanu, P. Mickey Williams, Zora Modrusan, Burt G. Feuerstein & Ken Aldape. (2006) Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9:3, pages 157-173.
Crossref
Crossref
David A. Reardon & Patrick Y. Wen. (2006) Therapeutic Advances in the Treatment of Glioblastoma: Rationale and Potential Role of Targeted Agents. The Oncologist 11:2, pages 152-164.
Crossref
Crossref
C. Jubert, B. Geoerger, J. Grill, O. Hartmann & G. Vassal. (2006) Thérapies ciblées en oncologie pédiatrique : nouvelle approche thérapeutique. Archives de Pédiatrie 13:2, pages 189-194.
Crossref
Crossref
Xiu-Huai Liu, Erik Z. Yu, Ying-Yue Li, Florence M. Rollwagen & Elliott Kagan. (2006) RNA interference targeting Akt promotes apoptosis in hypoxia-exposed human neuroblastoma cells. Brain Research 1070:1, pages 24-30.
Crossref
Crossref
Herbert B. Newton. 2006. Handbook of Brain Tumor Chemotherapy. Handbook of Brain Tumor Chemotherapy
463
474
.
Herbert B. Newton. 2006. Handbook of Brain Tumor Chemotherapy. Handbook of Brain Tumor Chemotherapy
439
447
.
Herbert B. Newton. 2006. Handbook of Brain Tumor Chemotherapy. Handbook of Brain Tumor Chemotherapy
407
425
.
Herbert B. Newton. 2006. Handbook of Brain Tumor Chemotherapy. Handbook of Brain Tumor Chemotherapy
347
363
.
Till Acker & Karl H. Plate. 2006. Handbook of Brain Tumor Chemotherapy. Handbook of Brain Tumor Chemotherapy
219
235
.
Herbert B. Newton. 2006. Handbook of Brain Tumor Chemotherapy. Handbook of Brain Tumor Chemotherapy
21
43
.
Santosh Kesari, Naren Ramakrishna, Claire Sauvageot, Charles D. Stiles & Patrick Y. Wen. (2006) Targeted molecular therapy of malignant gliomas. Current Oncology Reports 8:1, pages 58-70.
Crossref
Crossref
Neslihan Cetin, Gerald Dienel & Murat Gokden. (2005) CD117 expression in glial tumors. Journal of Neuro-Oncology 75:2, pages 195-202.
Crossref
Crossref
Seth J. Corey. (2005) Targeted therapy: For kids, too. Pediatric Blood & Cancer 45:5, pages 623-634.
Crossref
Crossref
Chun-Sheng Kang, Pei-Yu Pu, Yan-He Li, Zhi-Yong Zhang, Ming-Zhe Qiu, Qiang Huang & Guang-Xiu Wang. (2005) An in vitro Study on the Suppressive Effect of Glioma Cell Growth Induced by Plasmid-Based Small Interference RNA (siRNA) Targeting Human Epidermal Growth Factor Receptor. Journal of Neuro-Oncology 74:3, pages 267-273.
Crossref
Crossref
M. Chatel, M. Frenay, C. Lebrun, V. Bourg & F. Fauchon. (2005) Gliomes de haut grade : astrocytomes anaplasiques et glioblastomes. EMC - Neurologie 2:3, pages 257-278.
Crossref
Crossref
Karsten Hemmrich, Klaus-D. Kröncke, Christoph V. Suschek & Victoria Kolb-Bachofen. (2005) What sense lies in antisense inhibition of inducible nitric oxide synthase expression?. Nitric Oxide 12:4, pages 183-199.
Crossref
Crossref
Santosh Kesari, Naren Ramakrishna, Claire Sauvageot, Charles D. Stiles & Patrick Y. Wen. (2005) Targeted molecular therapy of malignant gliomas. Current Neurology and Neuroscience Reports 5:3, pages 186-197.
Crossref
Crossref
Balveen Kaur, Fatima W. Khwaja, Eric A. Severson, Shannon L. Matheny, Daniel J. Brat & Erwin G. Van Meir. (2005) Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and
angiogenesis. Neuro-Oncology 7:2, pages 134-153.
Crossref
Crossref
Florence Lefranc, Jacques Brotchi & Robert Kiss. (2005) Possible Future Issues in the Treatment of Glioblastomas: Special Emphasis on Cell Migration and the Resistance of Migrating Glioblastoma Cells to Apoptosis. Journal of Clinical Oncology 23:10, pages 2411-2422.
Crossref
Crossref
Nicholas ButowskiSusan M. Chang. (2017) Small Molecule and Monoclonal Antibody Therapies in Neurooncology. Cancer Control 12:2, pages 116-124.
Crossref
Crossref
Gitte Petersen, Birthe Moesgaard, Patricia C. Schmid, Harald H. O. Schmid, Helle Broholm, Michael Kosteljanetz & Harald S. Hansen. (2005) Endocannabinoid metabolism in human glioblastomas and meningiomas compared to human non-tumour brain tissue. Journal of Neurochemistry 93:2, pages 299-309.
Crossref
Crossref
Matthias P Wymann & Romina Marone. (2005) Phosphoinositide 3-kinase in disease: timing, location, and scaffolding. Current Opinion in Cell Biology 17:2, pages 141-149.
Crossref
Crossref
M. Chatel, M. Frenay, C. Lebrun, V. Bourg & F. Fauchon. (2005) Gliomes de haut grade : astrocytomes anaplasiques et glioblastomes. EMC - Neurologie 2:3, pages 1-15.
Crossref
Crossref
Jan Drappatz & Patrick Y Wen. (2004) Non-cytotoxic drugs as potential treatments for gliomas. Current Opinion in Neurology 17:6, pages 663-673.
Crossref
Crossref
Patrick Y. Wen & Santosh Kesari. (2004) Malignant gliomas. Current Neurology and Neuroscience Reports 4:3, pages 218-227.
Crossref
Crossref